Dapagliflozin/metformin/saxagliptin - AstraZeneca
At a glance
- Drug Originator AstraZeneca
- Drug Class Adamantanes; Antihyperglycaemics; Azabicyclo compounds; Benzhydryl compounds; Biguanides; Chlorobenzenes; Dipeptides; Glucosides; Nitriles; Organic bridged compounds; Piperidines; Pyrans; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors; Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants ASTRAZENECA AB
- USA Patents 15
- NDAs 1
- International Patents 346
Table of Contents

Disclaimer